Tealwood Asset Management’s Krystal Biotech KRYS Stock Holding History

Tealwood Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81M	Sell	7,561 -103	-1%	-$30.8K	1.08%	30
2026 Q1	$1.98M	Sell	7,664 -49	-0.6%	-$13K	0.9%	45
2025 Q4	$1.9M	Sell	7,713 -189	-2%	-$39.8K	0.85%	50
2025 Q3	$1.4M	Sell	7,902 -281	-3%	-$42.1K	0.56%	92
2025 Q2	$1.13M	Buy	+8,183	New	+$1.2M	0.5%	105

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

CPIA

Cornell Pochily Investment Advisors Ithaca, New York $372M AUM 29.32% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

NWAG

Net Worth Advisory Group Sandy, Utah $397M AUM 29.92% 1-Year Est. Return

Tealwood Asset Management's KRYS Position: Q2 2026 in Review

Tealwood Asset Management reduced its Krystal Biotech (KRYS) stake by 1.3% in Q2 2026, selling an estimated $30.8K and leaving 7,561 shares worth $2.81M. The position accounts for 1.08% of the portfolio, ranked #30.

Tealwood Asset Management first reported a position in KRYS in Q2 2025 and has held it in 5 quarters since. 32 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Tealwood Asset Management held 7,561 shares of Krystal Biotech worth $2.81M as of Q2 2026.
Tealwood Asset Management sold 103 Krystal Biotech shares in Q2 2026, an estimated $30.8K.
Krystal Biotech made up 1.08% of Tealwood Asset Management's portfolio in Q2 2026, its #30 holding.
Tealwood Asset Management first reported a position in Krystal Biotech in Q2 2025 and has held it in 5 quarters since.
32 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.